Senator Sanders Investigates Skyrocketing Costs of Novo Nordisk’s Diabetes and Weight Loss Drugs

1. Bernie Sanders, U.S. Senator from Vermont, has launched an investigation into the high prices of Novo Nordisk's diabetes and weight loss drugs, Novos Ozempic and Wegovy.

2. Novo Nordisk is a Danish multinational pharmaceutical company known for its production of diabetes and obesity drugs.

3. Novos Ozempic and Wegovy are used for managing type 2 diabetes and obesity, respectively. Both drugs have been praised for their effectiveness but criticized for their high costs.

4. The investigation aims to understand the reasons behind the high prices of these drugs and their impact on patients' access to affordable healthcare.

5. The probe is part of Sanders' ongoing efforts to address the issue of high drug prices in the United States, which has been a significant concern for many Americans.

6. The investigation could lead to policy recommendations or legislative actions to make these and other drugs more affordable for patients.